Basic Information
| RNALocate ID: | RLID:11001865 |
| RNA Symbol: | hsa-miR-125a-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-125a-5p |
| RNA ID: | miRBase:MIMAT0000443 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001809 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001810 | Mitochondrion | Myotube | 27396686 |
| RLID:01001811 | Mitochondrion | Skeletal muscle cells | 27563705 |
| RLID:01001812 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001813 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001814 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001815 | Nucleolus | HeLa cells | 23940654 |
| RLID:01001816 | Nucleolus | Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001858 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001859 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001860 | Exosome | Breast milk | 22211110 |
| RLID:11001861 | Exosome | Brain tissue | 23382797 |
| RLID:11001862 | Exosome | Plasma | 23663360 |
| RLID:11001863 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001864 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001866 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11001867 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:11001868 | Microvesicle | Serum | 24797360 |
| RLID-D:11000091 | Exosome | Blood|Breast milk|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000371 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-125a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-07005 |
| MNDR | hsa-miR-125a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-07006 |
| MNDR | hsa-miR-125a-5p | Oral squamous cell carcinoma | MNDR-E-MI-07007 |
| MNDR | hsa-miR-125a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-07008 |
| MNDR | hsa-miR-125a-5p | Medulloblastoma | MNDR-E-MI-07009 |
| MNDR | hsa-miR-125a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-07010 |
| MNDR | hsa-miR-125a-5p | Lymphoma | MNDR-E-MI-07011 |
| MNDR | hsa-miR-125a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-07012 |
| MNDR | hsa-miR-125a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-07013 |
| MNDR | hsa-miR-125a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-07014 |
| MNDR | hsa-miR-125a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-07015 |
| MNDR | hsa-miR-125a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-07016 |
| MNDR | hsa-miR-125a-5p | Breast cancer luminal | MNDR-E-MI-07017 |
| MNDR | hsa-miR-125a-5p | Anencephaly | MNDR-E-MI-07018 |
| MNDR | hsa-miR-125a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-07019 |
| MNDR | hsa-miR-125a-5p | Prostate cancer | MNDR-E-MI-07020 |
| MNDR | hsa-miR-125a-5p | Prostate carcinoma | MNDR-E-MI-07021 |
| MNDR | hsa-miR-125a-5p | Gastric cancer | MNDR-E-MI-07022 |
| MNDR | hsa-miR-125a-5p | Alzheimer disease | MNDR-E-MI-07023 |
| MNDR | hsa-miR-125a-5p | Intracranial aneurysm | MNDR-E-MI-07024 |
| MNDR | hsa-miR-125a-5p | Esophageal carcinoma | MNDR-E-MI-07025 |
| MNDR | hsa-miR-125a-5p | Dysautonomia familial | MNDR-E-MI-07026 |
| MNDR | hsa-miR-125a-5p | Leukemia | MNDR-E-MI-07027 |
| MNDR | hsa-miR-125a-5p | Acute leukemia | MNDR-E-MI-07028 |
| MNDR | hsa-miR-125a-5p | Cardiovascular disease | MNDR-E-MI-07029 |
| MNDR | hsa-miR-125a-5p | Lung cancer | MNDR-E-MI-07030 |
| MNDR | hsa-miR-125a-5p | Parkinson disease | MNDR-E-MI-07031 |
| MNDR | hsa-miR-125a-5p | Basal-like breast cancer | MNDR-E-MI-07032 |
| MNDR | hsa-miR-125a-5p | Vascular diseases | MNDR-E-MI-07033 |
| MNDR | hsa-miR-125a-5p | Thyroid cancer | MNDR-E-MI-07034 |
| MNDR | hsa-miR-125a-5p | Pancreatic cancer | MNDR-E-MI-07035 |
| MNDR | hsa-miR-125a-5p | Malignant melanoma | MNDR-E-MI-07036 |
| MNDR | hsa-miR-125a-5p | Rectum adenocarcinoma | MNDR-E-MI-07037 |
| MNDR | hsa-miR-125a-5p | Colon cancer | MNDR-E-MI-07038 |
| MNDR | hsa-miR-125a-5p | Colon adenocarcinoma | MNDR-E-MI-07039 |
| MNDR | hsa-miR-125a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-07040 |
| MNDR | hsa-miR-125a-5p | Ovarian cancer | MNDR-E-MI-07041 |
| MNDR | hsa-miR-125a-5p | Basal cell carcinoma | MNDR-E-MI-07042 |
| MNDR | hsa-miR-125a-5p | Prostate adenocarcinoma | MNDR-E-MI-07043 |
| MNDR | hsa-miR-125a-5p | Carcinoma ductal breast | MNDR-E-MI-07044 |
| MNDR | hsa-miR-125a-5p | Glioblastoma | MNDR-E-MI-07045 |
| MNDR | hsa-miR-125a-5p | Astrocytoma | MNDR-E-MI-07046 |
| MNDR | hsa-miR-125a-5p | Glioma | MNDR-E-MI-07047 |
| MNDR | hsa-miR-125a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-07048 |
| MNDR | hsa-miR-125a-5p | Chordoma | MNDR-E-MI-07049 |
| MNDR | hsa-miR-125a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-07050 |
| MNDR | hsa-miR-125a-5p | Osteosarcoma | MNDR-E-MI-07051 |
| MNDR | hsa-miR-125a-5p | Carotid artery thrombosis | MNDR-E-MI-07052 |
| MNDR | hsa-miR-125a-5p | Inclusion body myositis | MNDR-E-MI-07053 |
| MNDR | hsa-miR-125a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-07054 |
| MNDR | hsa-miR-125a-5p | Meningioma | MNDR-E-MI-07055 |
| MNDR | hsa-miR-125a-5p | Uterine cancer | MNDR-E-MI-07056 |
| MNDR | hsa-miR-125a-5p | Cervical adenocarcinoma | MNDR-E-MI-07057 |
| MNDR | hsa-miR-125a-5p | Gastric adenocarcinoma | MNDR-E-MI-07058 |
| MNDR | hsa-miR-125a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-07059 |
| MNDR | hsa-miR-125a-5p | Lung squamous cell carcinoma | MNDR-E-MI-07060 |
| MNDR | hsa-miR-125a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-07061 |
| MNDR | hsa-miR-125a-5p | Lung adenocarcinoma | MNDR-E-MI-07062 |
| MNDR | hsa-miR-125a-5p | Adrenocortical cancer | MNDR-E-MI-07063 |
| MNDR | hsa-miR-125a-5p | Thyroid carcinoma | MNDR-E-MI-07064 |
| MNDR | hsa-miR-125a-5p | Bladder urothelial carcinoma | MNDR-E-MI-07065 |
| MNDR | hsa-miR-125a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-07066 |
| MNDR | hsa-miR-125a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-07067 |
| MNDR | hsa-miR-125a-5p | Carcinoma renal cell | MNDR-E-MI-07068 |
| MNDR | hsa-miR-125a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-07069 |
| MNDR | hsa-miR-125a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-07070 |
| MNDR | hsa-miR-125a-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-07071 |
| MNDR | hsa-miR-125a-5p | Cholangiocarcinoma | MNDR-E-MI-07072 |
| MNDR | hsa-miR-125a-5p | Thyroid gland disease | MNDR-E-MI-07073 |
| MNDR | hsa-miR-125a-5p | Esophageal cancer | MNDR-E-MI-07074 |
| MNDR | hsa-miR-125a-5p | Liver cirrhosis | MNDR-E-MI-07075 |
| MNDR | hsa-miR-125a-5p | Encephalopathy bovine spongiform | MNDR-E-MI-07076 |
| MNDR | hsa-miR-125a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-07077 |
| MNDR | hsa-miR-125a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-07078 |
| MNDR | hsa-miR-125a-5p | Acute t cell leukemia | MNDR-E-MI-07079 |
| MNDR | hsa-miR-125a-5p | Fibromyalgia | MNDR-E-MI-07080 |
| MNDR | hsa-miR-125a-5p | Breast invasive carcinoma | MNDR-E-MI-07081 |
| MNDR | hsa-miR-125a-5p | Cerebrovascular disease | MNDR-E-MI-07082 |
| MNDR | hsa-miR-125a-5p | Juvenile rheumatoid arthritis | MNDR-E-MI-07083 |
| MNDR | hsa-miR-125a-5p | Hepatocellular carcinoma | MNDR-E-MI-07084 |
| MNDR | hsa-miR-125a-5p | Rheumatoid arthritis | MNDR-E-MI-07085 |
| MNDR | hsa-miR-125a-5p | Malignant pleural mesothelioma | MNDR-E-MI-07086 |
| MNDR | hsa-miR-125a-5p | Retinoblastoma | MNDR-E-MI-07087 |
| MNDR | hsa-miR-125a-5p | Neuroblastoma | MNDR-E-MI-07088 |
| MNDR | hsa-miR-125a-5p | Barrett's adenocarcinoma | MNDR-E-MI-07089 |
| MNDR | hsa-miR-125a-5p | Hodgkin lymphoma | MNDR-E-MI-07090 |
| MNDR | hsa-miR-125a-5p | Crohn disease | MNDR-E-MI-07091 |
| MNDR | hsa-miR-125a-5p | Tonsil cancer | MNDR-E-MI-07092 |
| MNDR | hsa-miR-125a-5p | Systemic lupus erythematosus | MNDR-E-MI-07093 |
| MNDR | hsa-miR-125a-5p | Acute myeloid leukemia | MNDR-E-MI-07094 |
| MNDR | hsa-miR-125a-5p | Colorectal cancer | MNDR-E-MI-07095 |
| MNDR | hsa-miR-125a-5p | Nasopharynx carcinoma | MNDR-E-MI-07096 |
| MNDR | hsa-miR-125a-5p | Type 2 diabetes mellitus | MNDR-E-MI-07097 |
| MNDR | hsa-miR-125a-5p | Multiple myeloma | MNDR-E-MI-07098 |
| MNDR | hsa-miR-125a-5p | Recurrent pregnancy loss | MNDR-E-MI-07099 |
| MNDR | hsa-miR-125a-5p | Ovarian epithelial cancer | MNDR-E-MI-07100 |
| MNDR | hsa-miR-125a-5p | Ependymoma | MNDR-E-MI-07101 |
| MNDR | hsa-miR-125a-5p | Nasopharyngeal cancer | MNDR-E-MI-07102 |
| MNDR | hsa-miR-125a-5p | Sleep deprivation | MNDR-E-MI-07103 |
| MNDR | hsa-miR-125a-5p | Wounds and injuries | MNDR-E-MI-07104 |
| MNDR | hsa-miR-125a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-07105 |
| MNDR | hsa-miR-125a-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-07106 |
| MNDR | hsa-miR-125a-5p | Pancreatitis chronic | MNDR-E-MI-07107 |
| MNDR | hsa-miR-125a-5p | Stroke lacunar | MNDR-E-MI-07108 |
| MNDR | hsa-miR-125a-5p | Barrett's carcinogenesis | MNDR-E-MI-07109 |
| MNDR | hsa-miR-125a-5p | Duke C | MNDR-E-MI-07110 |
| MNDR | hsa-miR-125a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-07111 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABL2 | Homo sapiens | RR00027148 |
TOP